Clincosm LogoSign in Get a demo

peripheral blood stem cell transplantation

Showing 1 - 14 of 14
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, Peripheral Blood Stem Cell Transplantation Trial (Eltrombopag olamine)

Not yet recruiting
  • Lymphoma
  • Peripheral Blood Stem Cell Transplantation
  • Eltrombopag olamine
  • (no location specified)
Jul 25, 2023

Peripheral Blood Stem Cell Transplantation, Hematopoietic Stem Cell Transplantation Trial run by the National Cancer Institute

Not yet recruiting
  • Peripheral Blood Stem Cell Transplantation
  • Hematopoietic Stem Cell Transplantation
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

Graft Vs Host Disease, Peripheral Blood Stem Cell Transplantation, AML Trial in Germany (Cyclophosphamide, ATG)

Recruiting
  • Graft Vs Host Disease
  • +5 more
  • Augsburg, Germany
  • +15 more
Aug 2, 2022

Peripheral Blood Stem Cell Transplantation Trial in Beijing (Modified By/Cy conditioning regimen intensified by Ruxolitinib and

Recruiting
  • Peripheral Blood Stem Cell Transplantation
  • Modified By/Cy conditioning regimen intensified by Ruxolitinib and Chidamide
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Dec 12, 2021

Peripheral Blood Stem Cell Transplantation Trial in Beijing (Ruxolitinib combined with Chidamide.)

Recruiting
  • Peripheral Blood Stem Cell Transplantation
  • Ruxolitinib combined with Chidamide.
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Oct 20, 2021

Factors Associated With Development and Severity of Oral

Completed
  • Peripheral Blood Stem Cell Transplantation
  • Mucositis and nutritional assessments
  • San Antonio, Texas
  • +1 more
Jul 19, 2021

Peripheral Blood Stem Cell Transplantation Trial in Sapporo (Pegfilgrastim)

Completed
  • Peripheral Blood Stem Cell Transplantation
  • Sapporo, Hokkaido, Japan
    Hokkaido University Hospital
Jan 20, 2021

Peripheral Blood Stem Cell Transplantation Trial in Beijing (modified By/Cy conditioning regimen intensified by Ruxolitinib and

Recruiting
  • Peripheral Blood Stem Cell Transplantation
  • modified By/Cy conditioning regimen intensified by Ruxolitinib and Decitabine
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Oct 19, 2020

Gut Microbiota, Inflammation and Symptoms Following Allogeneic

Completed
  • Graft vs Host Disease
  • +3 more
  • Questionnaires
  • +3 more
  • Gainesville, Florida
    UF Health Cancer Hospital
Jan 23, 2019

Donor Lymphocyte Infusion, Peripheral Blood Stem Cell Transplantation, Relapse Trial in Beijing (Prophylactic DLI)

Unknown status
  • Donor Lymphocyte Infusion
  • +4 more
  • Prophylactic DLI
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Dec 11, 2018

Mucositis, Hematopoietic Stem Cell Transplantation, Peripheral Blood Stem Cell Transplantation Trial in Gainesville (Ice, Normal

Terminated
  • Mucositis
  • +3 more
  • Ice
  • Normal Saline Solution
  • Gainesville, Florida
    UF Health Shands Cancer Hopsital
Dec 4, 2018

GVHD, Peripheral Blood Stem Cell Transplantation, Transplantation, Homologous Trial in Indianapolis (Tacrolimus, Sirolimus,

Completed
  • Graft vs Host Disease
  • +2 more
  • Indianapolis, Indiana
    Indiana University Melvin and Bren Simon Cancer Center
Aug 14, 2018

Stem Cell Transplantation, Bone Marrow Transplantation, Peripheral Blood Stem Cell Transplantation Trial (Cyclophosphamide Dose

Terminated
Has Results
  • Stem Cell Transplantation
  • +12 more
  • Cyclophosphamide Dose Level 1
  • +3 more
  • (no location specified)
Jan 12, 2017

Peripheral Blood Stem Cell Transplantation, aGVHD Trial in Shanghai (VPA)

Unknown status
  • Peripheral Blood Stem Cell Transplantation
  • aGVHD
  • Shanghai, Shanghai, China
    Blood & Marrow Transplantation Center, RuiJin Hospital
Jul 29, 2016